Found Health's telehealth weight loss platform has seen increased consumer interest from consumers researching GLP-1 medication access, insurance coverage pathways, and program pricing in 2026
5.2 Analytical Platforms and Quality Control for GSH/GSSG Measurement Once sample integrity has been protected, the analytical platform determines selectivity, sensitivity, throughput, and whether GSH and GSSG are measured directly
Victorino et al., 2014) (Table 2)
Employer coverage is rapidly expanding - 44% of large employers now cover GLP-1s for obesity, with 21% more considering coverage within three years
But one should be careful about aspects like sterility and hygiene, and the expertise of the person administering the treatment